Piatek Institute

The Piatek Institute in Carmel, Indiana, has delivered medically supervised weight loss programs since 1995, establishing nearly three decades of clinical experience in obesity medicine. Founded and directed by Dr. Jay Piatek, a board-certified obesity medicine physician, the Institute focuses exclusively on evidence-based weight management strategies that address the metabolic and hormonal factors underlying excess weight. Dr. Piatek's board certification in obesity medicine reflects specialized training beyond general medical practice, positioning the clinic to manage complex cases where traditional diet-and-exercise approaches have proven insufficient. Located in Carmel, the Institute serves patients throughout the Indianapolis metropolitan area and central Indiana seeking medical intervention for weight-related health concerns.

The Piatek Institute incorporates GLP-1 receptor agonist peptides as central components of its treatment protocols, specifically offering Semaglutide and Tirzepatide for eligible patients. Semaglutide functions by mimicking the glucagon-like peptide-1 hormone to regulate appetite and slow gastric emptying, while Tirzepatide activates both GLP-1 and GIP receptors for dual-pathway metabolic effects. Dr. Piatek evaluates each patient's medical history, current health status, comorbidities, and weight loss objectives to determine appropriate peptide therapy candidacy and dosing schedules. The clinic's protocols include baseline metabolic assessments, medication titration plans, and monitoring schedules designed to optimize therapeutic response while managing potential side effects. These peptide therapies address obesity as a chronic metabolic condition requiring pharmaceutical intervention rather than willpower alone, particularly for patients with BMI above 30 or above 27 with weight-related comorbidities.

Dr. Piatek's approach integrates medication management with nutritional guidance and behavioral modification strategies, recognizing that peptide therapy produces optimal results when combined with lifestyle adjustments. The Institute's programs include education on macronutrient balance, portion control, and sustainable eating patterns that support long-term weight maintenance beyond the active treatment phase. Patients receive instruction on recognizing hunger versus appetite cues, managing emotional eating triggers, and developing meal planning skills that align with their medication regimen. The clinic's nearly 30-year operational history has allowed Dr. Piatek to refine treatment algorithms based on thousands of patient outcomes, adapting protocols as new obesity medications and research findings emerge. This longitudinal experience informs clinical decision-making regarding medication selection, combination therapies, and transition strategies for patients approaching goal weight.

Patients at the Piatek Institute in Carmel attend in-person consultations where Dr. Piatek conducts physical examinations, reviews laboratory results, and adjusts treatment plans based on progress metrics including weight trends, body composition changes, and improvements in obesity-related conditions such as type 2 diabetes, hypertension, or sleep apnea. The clinic's 4.8-star rating across 59 Google reviews reflects patient feedback on the medical team's responsiveness to questions, thoroughness in explaining medication mechanisms and expected timelines, and support throughout the weight loss process. Office visits typically include weight and vital sign measurements, discussion of any side effects or challenges encountered since the previous appointment, and medication refills or dosage adjustments as clinically indicated. The Institute's focus on education ensures patients understand how their prescribed peptides function, why specific dietary recommendations enhance medication efficacy, and what realistic expectations exist for weekly weight loss rates and total reduction over treatment duration.

The Piatek Institute's exclusive focus on obesity medicine distinguishes it from general wellness clinics offering weight loss as one service among many. Dr. Piatek's board certification and the clinic's 1995 establishment date predate the recent surge in GLP-1 peptide popularity, indicating sustained expertise in medical weight management across multiple generations of obesity pharmacotherapy. The Carmel location provides accessible care for Indiana residents seeking specialized obesity treatment without traveling to academic medical centers, while the in-person consultation model allows for hands-on clinical assessment and immediate problem-solving when patients experience medication side effects or weight loss plateaus. The Institute's treatment philosophy positions obesity as a treatable medical condition warranting the same pharmaceutical intervention approach applied to other chronic diseases, offering patients evidence-based tools beyond conventional diet programs.